White label ELPA - ClinicalTrials.eu

Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic myeloid leukaemia
Investigated drugs:
Study on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease

Not recruiting

1 1 1
Investigated diseases:
- White matter lesion
Investigated drugs:
- Guanabenz Acetate
Study of belantamab mafodotin with bortezomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Effects of TransCon CNP in Children Aged 2-11 with Achondroplasia

Not recruiting

2 1
Investigated diseases:
- Osteochondrodysplasia
Investigated drugs:
- C-Type Natriuretic Peptide Conjugated To A Multi-Arm Polyethylene Glycol Carrier Molecule Through A Cleavable Linker
Study of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure

Not recruiting

2 1 1 1
Investigated diseases:
- Glioblastoma multiforme
Investigated drugs:
- Berubicin Hydrochloride
- Lomustine
Study Comparing Cemiplimab to Platinum-Based Chemotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Evencaleucel
- Isatuximab
Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

Not recruiting

4 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Effectiveness and Safety of Olaparib Alone and with Durvalumab for Patients with Early Stage HER2-Negative Breast Cancer with BRCA Mutations

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Rectal cancer
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies